Literature DB >> 21340479

Unliganded progesterone receptors attenuate taxane-induced breast cancer cell death by modulating the spindle assembly checkpoint.

Melanie M Badtke1, Purevsuren Jambal, Wendy W Dye, Monique A Spillman, Miriam D Post, Kathryn B Horwitz, Britta M Jacobsen.   

Abstract

Whether the presence of steroid receptors in luminal breast cancers renders them resistant to taxanes remains uncertain. Here we assess the role of progesterone receptors (PR) on taxane-induced cell death. We previously showed that estrogen receptor (ER)-positive human breast cancer cells that inducibly express PR-A or PR-B isoforms were protected from taxane-stimulated apoptosis when compared to the identical cells lacking PR. Surprisingly, PR-dependent protection occurred in the absence of progesterone, demonstrating that the unliganded receptors were biologically active. The present studies demonstrate that unliganded PR, focused on PR-A, protect breast cancer cells from taxane-stimulated apoptosis. The studies identify genes regulated by taxanes in isogenic ER-positive cells that either lack or express PR-A. We show that unliganded PR-A alters the gene expression pattern controlled by taxanes, especially multiple genes involved in the spindle assembly checkpoint, a group of proteins that insure proper attachment of microtubules to kinetochores during mitosis. Importantly, taxanes and unliganded PR regulate many of these genes in opposite directions. As a result, mitotic slippage is exacerbated by the presence of PR, leading to an increase in the number of multinucleated cells both in vitro and in xenograft tumors. We describe a simple new assay for assessing multinucleation in paraffin sections. We speculate that rather than inducing cell death, unliganded PR exploits multinucleation to promote cell survival from taxane therapy. This can be prevented with antiprogestin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21340479      PMCID: PMC3875321          DOI: 10.1007/s10549-011-1399-0

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  55 in total

1.  Survival of docetaxel-resistant prostate cancer cells in vitro depends on phenotype alterations and continuity of drug exposure.

Authors:  A N Makarovskiy; E Siryaporn; D C Hixson; W Akerley
Journal:  Cell Mol Life Sci       Date:  2002-07       Impact factor: 9.261

2.  A multistep model for paclitaxel-induced apoptosis in human breast cancer cell lines.

Authors:  A L Blajeski; T J Kottke; S H Kaufmann
Journal:  Exp Cell Res       Date:  2001-11-01       Impact factor: 3.905

3.  Differential regulation of anaphase promoting complex/cyclosome substrates by the spindle assembly checkpoint in Saccharomyces cerevisiae.

Authors:  Brice E Keyes; Christopher M Yellman; Daniel J Burke
Journal:  Genetics       Date:  2008-01       Impact factor: 4.562

4.  Mad2 overexpression promotes aneuploidy and tumorigenesis in mice.

Authors:  Rocío Sotillo; Eva Hernando; Elena Díaz-Rodríguez; Julie Teruya-Feldstein; Carlos Cordón-Cardo; Scott W Lowe; Robert Benezra
Journal:  Cancer Cell       Date:  2006-12-28       Impact factor: 31.743

5.  Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.

Authors:  Bibo Yuan; Yi Xu; Ju-Hyung Woo; Yunyue Wang; Young Kyung Bae; Dae-Sung Yoon; Robert P Wersto; Ellen Tully; Kathleen Wilsbach; Edward Gabrielson
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

6.  Antitumor activity of an allosteric inhibitor of centromere-associated protein-E.

Authors:  Kenneth W Wood; Latesh Lad; Lusong Luo; Xiangping Qian; Steven D Knight; Neysa Nevins; Katjusa Brejc; David Sutton; Aidan G Gilmartin; Penelope R Chua; Radhika Desai; Stephen P Schauer; Dean E McNulty; Roland S Annan; Lisa D Belmont; Carlos Garcia; Yan Lee; Melody A Diamond; Leo F Faucette; Michele Giardiniere; Shuyun Zhang; Chiu-Mei Sun; Justin D Vidal; Serge Lichtsteiner; William D Cornwell; Joel D Greshock; Richard F Wooster; Jeffrey T Finer; Robert A Copeland; Pearl S Huang; David J Morgans; Dashyant Dhanak; Gustave Bergnes; Roman Sakowicz; Jeffrey R Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-18       Impact factor: 11.205

7.  Complete loss of the tumor suppressor MAD2 causes premature cyclin B degradation and mitotic failure in human somatic cells.

Authors:  Loren Michel; Elena Diaz-Rodriguez; Gopeshwar Narayan; Eva Hernando; Vundavalli V V S Murty; Robert Benezra
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

8.  Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer.

Authors:  P M Ravdin; H A Burris; G Cook; P Eisenberg; M Kane; W A Bierman; J Mortimer; E Genevois; R E Bellet
Journal:  J Clin Oncol       Date:  1995-12       Impact factor: 44.544

Review 9.  Taxanes, microtubules and chemoresistant breast cancer.

Authors:  Barbara T McGrogan; Breege Gilmartin; Desmond N Carney; Amanda McCann
Journal:  Biochim Biophys Acta       Date:  2007-11-12

Review 10.  Aurora kinase inhibitors in preclinical and clinical testing.

Authors:  Chun Hei Antonio Cheung; Mohane Selvaraj Coumar; Hsing-Pang Hsieh; Jang-Yang Chang
Journal:  Expert Opin Investig Drugs       Date:  2009-04       Impact factor: 6.206

View more
  7 in total

1.  Mucin 2 (MUC2) modulates the aggressiveness of breast cancer.

Authors:  Anna Astashchanka; Thomas M Shroka; Britta M Jacobsen
Journal:  Breast Cancer Res Treat       Date:  2018-10-13       Impact factor: 4.872

2.  Progestin modulates the lipid profile and sensitivity of breast cancer cells to docetaxel.

Authors:  Isabel R Schlaepfer; Carolyn A Hitz; Miguel A Gijón; Bryan C Bergman; Robert H Eckel; Britta M Jacobsen
Journal:  Mol Cell Endocrinol       Date:  2012-08-16       Impact factor: 4.102

3.  Progesterone receptor activates Msx2 expression by downregulating TNAP/Akp2 and activating the Bmp pathway in EpH4 mouse mammary epithelial cells.

Authors:  Jodie M Fleming; Erika Ginsburg; Anita S Goldhar; Joshua Plant; Barbara K Vonderhaar
Journal:  PLoS One       Date:  2012-03-22       Impact factor: 3.240

4.  Estrogen induces c-Kit and an aggressive phenotype in a model of invasive lobular breast cancer.

Authors:  J Chuck Harrell; Thomas M Shroka; Britta M Jacobsen
Journal:  Oncogenesis       Date:  2017-11-27       Impact factor: 7.485

5.  SUMOylation Regulates Transcription by the Progesterone Receptor A Isoform in a Target Gene Selective Manner.

Authors:  Hany A Abdel-Hafiz; Michelle L Dudevoir; Daniel Perez; Mohamed Abdel-Hafiz; Kathryn B Horwitz
Journal:  Diseases       Date:  2018-01-02

6.  N-glycosylation is required for secretion and mitosis in C. elegans.

Authors:  Julia Stevens; Anne Spang
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

7.  The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer.

Authors:  Gonzalo Sequeira; Silvia I Vanzulli; Paola Rojas; Caroline Lamb; Lucas Colombo; Maria May; Alfredo Molinolo; Claudia Lanari
Journal:  Oncotarget       Date:  2014-05-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.